Terminal
Stocks
Spotlight
Research

Stocks
Healthcare
NASDAQ
BTMD

Market Cap: $58.66M

BC

biote Corp.

BTMD

NASDAQ (NASDAQ Global Market)USD

Overview News Analyst Reports Financials Politician Trades Insider Trades Executive Patents Earnings Surprise

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

Stocks About Advertisers Brokers Contact

Legal

Terms of Service Privacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability

Gross Profit Margin60.23%

EBITDA Margin12.79%

EBIT Margin10.69%

Pre-tax Margin5.59%

Net Profit Margin3.19%

Earnings Yield15.38%

Valuation Multiples

Price / Book-0.58

Price / Sales0.32

Price / Earnings7.92

PEG-0.10

Forward PEG0.01

EV / Sales0.96

EV / EBITDA7.51

EV / Operating Cash Flow7.23

EV / Free Cash Flow8.95

Price / Free Cash Flow2.98

Price / Operating Cash Flow1.56

Cash Flow & Capital

Free Cash Flow / Share$0.69

Operating Cash Flow / Share$0.85

Free Cash Flow Yield33.55%

Capex / Revenue2.55%

Capex / Operating Cash Flow19.23%

Capex / Depreciation1.22

Stock Compensation / Revenue4.54%

Dividend Payout Ratio2.49%

Dividend Yield0.00%

Liquidity & Leverage

Current Ratio1.43

Quick Ratio0.82

Cash Ratio0.37

Debt / Assets1.26

Debt / Capital2.05

Debt / Equity-1.96

Long-Term Debt / Capital2.25

Debt / Market Cap2.07%

Net Debt / EBITDA5.01

Solvency Ratio0.06

Financial Leverage-1.55

Efficiency & Working Capital

Asset Turnover1.80

Fixed Asset Turnover9.32

Inventory Turnover3.98

Receivables Turnover23.50

Payables Turnover11.10

Days Sales Outstanding15.53

Days Inventory Outstanding91.68

Days Payables Outstanding32.89

Operating Cycle107.21

Cash Conversion Cycle74.32

Working Capital Turnover17.42

Returns & Quality

Return on Equity-9.25%

Return on Assets5.76%

Return on Invested Capital13.50%

ROCE20.61%

Return on Tangible Assets6.71%

Operating Return on Assets15.47%

Income Quality3.44

Tax Burden0.57

Interest Burden0.52

Balance Sheet & Intrinsic Metrics

Enterprise Value$176.14M

Invested Capital$47.01M

Working Capital$12.94M

Tangible Asset Value$-72.57M

Net Current Asset Value$-116.85M

Graham Net-Net-$4.67

Book Value / Share-$2.03

Tangible Book Value / Share-$2.54

Cash / Share$0.39

Financial Health Scores

Piotroski Score7

Altman Z-Score2.11

Revenue$183.53M

EBIT$19.62M

Market Cap$57.78M

Working Capital$12.94M

Retained Earnings$-50.94M

Total Assets$101.7M

Total Liabilities$159.89M